AZD6280
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for AZD6280, covering 2009-06-26 to 2010-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280 [Phase 1]